This finding was consistent with the lower tumor expression levels of phospho-tuberin T1462 and phospho-PRAS40 T246—both of which are substrates of AKT—in patients having the high adiposity with low muscle body composition type [26,27,28]. This evidence concerns the gene AKT1 and neoplasm.